Difference between revisions of "Ultrasound CEUS BC"

From QIBA Wiki
Jump to navigation Jump to search
(12 intermediate revisions by the same user not shown)
Line 19: Line 19:
'''Approved Call Summaries:'''
'''Approved Call Summaries:'''
*[[Media:03 12 2021 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 12, 2021]]
*[[Media:05 13 2022 QIBA CEUS BC Call Summary-FINAL.pdf|May 13, 2022]]
*[[Media:02 12 2021 QIBA CEUS BC Call Summary-FINAL-MA.pdf|February 12, 2021]]
*[[Media:03 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|March 11, 2022]]
*[[Media:02 11 2022 QIBA CEUS BC Call Summary-FINAL.pdf|February 11, 2022]]
*[[Media:01 14 2022 QIBA CEUS BC Call Summary-FINAL.pdf|January 14, 2022]]

Revision as of 15:39, 6 May 2022

Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
RSNA Staff Support: Julie Lisiecki

Project Snapshot

The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.

Project Descriptions:

CEUS Biomarker Committee Proposal:

Recent Meetings

Approved Call Summaries:

US CEUS Call Summary Archive

CEUS Task Force (TF) Call Summaries

Working Documents

Statistical Reference Documents

Workflow Documents

Historical Background - Formation of the Group

Reference Materials

Original Proposal to the QIBA Steering Committee:

Vendor Press Release: